Insulin resistance and hyperandrogenism directly affect each other and can exacerbate hyperandrogenism through actions on the hypothalamus
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
We also do a full intake, which includes blood tests, to ensure youre a good fit. Semaglutide treatments can be used as an alternative to bariatric surgery for some patients who have obesity
Clinicaltrials.gov identifier: NCT06903923
names to watch: Januvia and Galvus The FDA recently approved the first DPP-4 inhibitor, called Januvia, and the agency is expected to approve a second one, Galvus, later this year
Nearly 72% of participants with prediabetes achieved normoglycemia by study conclusion, suggesting potential disease-modifying effects beyond symptomatic treatment